{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:00:24Z","timestamp":1781647224694,"version":"3.54.5"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute of Health research project","doi-asserted-by":"crossref","award":["2020-NI016-02"],"award-info":[{"award-number":["2020-NI016-02"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Tuberculosis (TB), caused by\n                      <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                      (\n                      <jats:italic>M.tb<\/jats:italic>\n                      ), remains a major public health problem worldwide. The development of effective drugs and vaccines remains crucial but the prolonged culture period of\n                      <jats:italic>M.tb<\/jats:italic>\n                      hampers this process. This limitation has been addressed by developing a bioluminescent\n                      <jats:italic>M.tb<\/jats:italic>\n                      strain that can be used to measure bacterial burden in live animals non-invasively and in real time. We investigated whether bioluminescence real-time imaging technologies could be used to monitor the infection process in live mice, with the aim of facilitating TB research.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this study, we constructed bioluminescence-expressing\n                      <jats:italic>M.tb<\/jats:italic>\n                      strains. We compared the growth of these recombinant reporter and wild-type (WT) strains to confirm their stability in vitro. BALB\/c mice were infected via intranasal or intravenous routes and monitored using an In Vivo Imaging System. The efficacy of isoniazid treatment was assessed using bioluminescence imaging and confirmed using colony-forming unit (CFU) assays. In a separate experiment, BCG-vaccinated and na\u00efve control mice were infected with\n                      <jats:italic>M.tb<\/jats:italic>\n                      L5-Lux, a recombinant strain that expresses luxCDABE under the L5 promoter derived from the L5 mycobacteriophage. Vaccine efficacy was assessed by comparing bioluminescence and CFU counts.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The\n                      <jats:italic>M.tb<\/jats:italic>\n                      L5-Lux strain showed stable growth and a strong bioluminescent signal comparable to the WT strain. In both infection models, bioluminescence intensity strongly correlated with bacterial load. Isoniazid treatment led to a significant reduction in luminescence and CFU. In the vaccine study, BCG-vaccinated mice exhibited lower in vivo and ex vivo bioluminescence and approximately 0.5 log\u2081\u2080 lower CFU counts than na\u00efve controls, demonstrating the utility of the\n                      <jats:italic>M.tb<\/jats:italic>\n                      L5-Lux strain for vaccine efficacy assessment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The\n                      <jats:italic>M.tb<\/jats:italic>\n                      L5-Lux bioluminescent reporter strain provides a sensitive and efficient tool for monitoring\n                      <jats:italic>M.tb<\/jats:italic>\n                      infection and evaluating anti-TB drug and vaccine efficacy in real time. This imaging-based platform facilitates faster and more ethical preclinical testing by reducing the number of animals and experimental duration.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-13140-w","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T11:55:17Z","timestamp":1775908517000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Application of luminescence-producing Mycobacterium tuberculosis strains for evaluating anti-tuberculosis drug and vaccine efficacy in vitro and in vivo"],"prefix":"10.1186","volume":"26","author":[{"given":"Soo-Min","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunkyung","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Seung","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeseon","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohee","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Woo","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dokeun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Sook","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,11]]},"reference":[{"issue":"14","key":"13140_CR1","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1056\/NEJMp2000325","volume":"382","author":"A Zaheen","year":"2020","unstructured":"Zaheen A, Bloom BR. Tuberculosis in 2020 \u2014 New Approaches to a Continuing Global Health Crisis. N Engl J Med. 2020;382(14):e26.","journal-title":"N Engl J Med"},{"issue":"1","key":"13140_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jceh.2012.12.001","volume":"3","author":"V Ramappa","year":"2013","unstructured":"Ramappa V, Aithal GP. Hepatotoxicity Related to Anti-tuberculosis Drugs: Mechanisms and Management. J Clin experimental Hepatol. 2013;3(1):37\u201349.","journal-title":"J Clin experimental Hepatol"},{"issue":"1","key":"13140_CR3","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1016\/S2666-5247(22)00359-7","volume":"4","author":"S Bagcchi","year":"2023","unstructured":"Bagcchi S. WHO\u2019s Global Tuberculosis Report 2022. Lancet Microbe. 2023;4(1):e20.","journal-title":"Lancet Microbe"},{"issue":"8","key":"13140_CR4","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nrmicro3299","volume":"12","author":"KJ Kieser","year":"2014","unstructured":"Kieser KJ, Rubin EJ. How sisters grow apart: mycobacterial growth and division. Nat Rev Microbiol. 2014;12(8):550\u201362.","journal-title":"Nat Rev Microbiol"},{"key":"13140_CR5","doi-asserted-by":"crossref","unstructured":"Chang MH, Cirillo SL, Cirillo JD. Using luciferase to image bacterial infections in mice. J visualized experiments: JoVE. 2011(48).","DOI":"10.3791\/2547"},{"issue":"1","key":"13140_CR6","doi-asserted-by":"publisher","first-page":"e29774","DOI":"10.1371\/journal.pone.0029774","volume":"7","author":"T Zhang","year":"2012","unstructured":"Zhang T, Li SY, Nuermberger EL. Autoluminescent Mycobacterium tuberculosis for rapid, real-time, non-invasive assessment of drug and vaccine efficacy. PLoS ONE. 2012;7(1):e29774.","journal-title":"PLoS ONE"},{"issue":"5","key":"13140_CR7","doi-asserted-by":"publisher","first-page":"e10777","DOI":"10.1371\/journal.pone.0010777","volume":"5","author":"N Andreu","year":"2010","unstructured":"Andreu N, Zelmer A, Fletcher T, Elkington PT, Ward TH, Ripoll J, Parish T, Bancroft GJ, Schaible U, Robertson BD, et al. Optimisation of bioluminescent reporters for use with mycobacteria. PLoS ONE. 2010;5(5):e10777.","journal-title":"PLoS ONE"},{"issue":"5","key":"13140_CR8","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1159\/000327655","volume":"20","author":"M Solomon","year":"2011","unstructured":"Solomon M, Liu Y, Berezin MY, Achilefu S. Optical imaging in cancer research: basic principles, tumor detection, and therapeutic monitoring. Med principles practice: Int J Kuwait Univ Health Sci Centre. 2011;20(5):397\u2013415.","journal-title":"Med principles practice: Int J Kuwait Univ Health Sci Centre"},{"issue":"2","key":"13140_CR9","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1574-6976.2010.00252.x","volume":"35","author":"N Andreu","year":"2011","unstructured":"Andreu N, Zelmer A, Wiles S. Noninvasive biophotonic imaging for studies of infectious disease. FEMS Microbiol Rev. 2011;35(2):360\u201394.","journal-title":"FEMS Microbiol Rev"},{"issue":"9","key":"13140_CR10","doi-asserted-by":"publisher","first-page":"e108341","DOI":"10.1371\/journal.pone.0108341","volume":"9","author":"M Chang","year":"2014","unstructured":"Chang M, Anttonen KP, Cirillo SLG, Francis KP, Cirillo JD. Real-Time Bioluminescence Imaging of Mixed Mycobacterial Infections. PLoS ONE. 2014;9(9):e108341.","journal-title":"PLoS ONE"},{"issue":"10","key":"13140_CR11","doi-asserted-by":"publisher","first-page":"6275","DOI":"10.1021\/acs.analchem.8b00985","volume":"90","author":"L Blanc","year":"2018","unstructured":"Blanc L, Lenaerts A, Dartois V, Prideaux B. Visualization of Mycobacterial Biomarkers and Tuberculosis Drugs in Infected Tissue by MALDI-MS Imaging. Anal Chem. 2018;90(10):6275\u201382.","journal-title":"Anal Chem"},{"issue":"9","key":"13140_CR12","doi-asserted-by":"publisher","first-page":"5668","DOI":"10.1039\/D0CS01492C","volume":"50","author":"AJ Syed","year":"2021","unstructured":"Syed AJ, Anderson JC. Applications of bioluminescence in biotechnology and beyond. Chem Soc Rev. 2021;50(9):5668\u2013705.","journal-title":"Chem Soc Rev"},{"key":"13140_CR13","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.mimet.2014.08.015","volume":"106","author":"MC Larsson","year":"2014","unstructured":"Larsson MC, Lerm M, \u00c4ngeby K, Nordvall M, Jur\u00e9en P, Sch\u00f6n T. A luciferase-based assay for rapid assessment of drug activity against Mycobacterium tuberculosis including monitoring of macrophage viability. J Microbiol Methods. 2014;106:146\u201350.","journal-title":"J Microbiol Methods"},{"issue":"2","key":"13140_CR14","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1128\/AAC.40.2.400","volume":"40","author":"MJ Hickey","year":"1996","unstructured":"Hickey MJ, Arain TM, Shawar RM, Humble DJ, Langhorne MH, Morgenroth JN, Stover CK. Luciferase in vivo expression technology: use of recombinant mycobacterial reporter strains to evaluate antimycobacterial activity in mice. Antimicrob Agents Chemother. 1996;40(2):400\u20137.","journal-title":"Antimicrob Agents Chemother"},{"issue":"24","key":"13140_CR15","doi-asserted-by":"publisher","first-page":"4455","DOI":"10.1007\/s00018-017-2584-z","volume":"74","author":"P Jurgielewicz","year":"2017","unstructured":"Jurgielewicz P, Harmsen S, Wei E, Bachmann MH, Ting R, Aras O. New imaging probes to track cell fate: reporter genes in stem cell research. Cell Mol Life Sci. 2017;74(24):4455\u201369.","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"13140_CR16","doi-asserted-by":"publisher","first-page":"e0149972","DOI":"10.1371\/journal.pone.0149972","volume":"11","author":"Y Kong","year":"2016","unstructured":"Kong Y, Yang D, Cirillo SLG, Li S, Akin A, Francis KP, Maloney T, Cirillo JD. Application of Fluorescent Protein Expressing Strains to Evaluation of Anti-Tuberculosis Therapeutic Efficacy in vitro and in vivo. PLoS ONE. 2016;11(3):e0149972.","journal-title":"PLoS ONE"},{"issue":"8","key":"13140_CR17","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1128\/AEM.03677-15","volume":"82","author":"AI Kanno","year":"2016","unstructured":"Kanno AI, Goulart C, Rofatto HK, Oliveira SC, Leite LCC, McFadden J. New Recombinant Mycobacterium bovis BCG Expression Vectors: Improving Genetic Control over Mycobacterial Promoters. Appl Environ Microbiol. 2016;82(8):2240\u20136.","journal-title":"Appl Environ Microbiol"},{"key":"13140_CR18","doi-asserted-by":"publisher","first-page":"591866","DOI":"10.3389\/fmicb.2020.591866","volume":"11","author":"K Kolbe","year":"2020","unstructured":"Kolbe K, Bell AC, Prosser GA, Assmann M, Yang HJ, Forbes HE, Gallucci S, Mayer-Barber KD, Boshoff HI. Barry Iii CE: Development and Optimization of Chromosomally-Integrated Fluorescent Mycobacterium tuberculosis Reporter Constructs. Front Microbiol. 2020;11:591866.","journal-title":"Front Microbiol"},{"issue":"1","key":"13140_CR19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1574-6968.1999.tb13604.x","volume":"175","author":"LP Barker","year":"1999","unstructured":"Barker LP, Porcella SF, Wyatt RG, Small PL. The Mycobacterium marinum G13 promoter is a strong sigma 70-like promoter that is expressed in Escherichia coli and mycobacteria species. FEMS Microbiol Lett. 1999;175(1):79\u201385.","journal-title":"FEMS Microbiol Lett"},{"key":"13140_CR20","doi-asserted-by":"crossref","unstructured":"Soldevilla P, Vilaplana C. Mouse models for mycobacterium tuberculosis pathogenesis: Show and Do Not Tell. 2022;12(1).","DOI":"10.3390\/pathogens12010049"},{"issue":"2","key":"13140_CR21","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s11307-021-01697-8","volume":"24","author":"N Shalaby","year":"2022","unstructured":"Shalaby N, Kelly J, Martinez F, Fox M, Qi Q, Thiessen J, Hicks J, Scholl TJ, Ronald JA. A Human-derived Dual MRI\/PET Reporter Gene System with High Translational Potential for Cell Tracking. Mol imaging biology. 2022;24(2):341\u201351.","journal-title":"Mol imaging biology"},{"issue":"6","key":"13140_CR22","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1111\/j.1365-2958.1995.mmi_17061045.x","volume":"17","author":"CE Nesbit","year":"1995","unstructured":"Nesbit CE, Levin ME, Donnelly-Wu MK, Hatfull GF. Transcriptional regulation of repressor synthesis in mycobacteriophage L5. Mol Microbiol. 1995;17(6):1045\u201356.","journal-title":"Mol Microbiol"},{"issue":"8","key":"13140_CR23","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1128\/AEM.03677-15","volume":"82","author":"I Kanno Alex","year":"2016","unstructured":"Kanno Alex I, Goulart C, Rofatto Henrique K, Oliveira Sergio C, Leite Luciana CC, McFadden J. New Recombinant Mycobacterium bovis BCG Expression Vectors: Improving Genetic Control over Mycobacterial Promoters. Appl Environ Microbiol. 2016;82(8):2240\u20136.","journal-title":"Appl Environ Microbiol"},{"issue":"1","key":"13140_CR24","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.abb.2006.07.016","volume":"454","author":"X Li","year":"2006","unstructured":"Li X, Tu S-C. Activity coupling of Vibrio harveyi luciferase and flavin reductase (FRP): Oxygen as a probe. Arch Biochem Biophys. 2006;454(1):26\u201331.","journal-title":"Arch Biochem Biophys"},{"issue":"3","key":"13140_CR25","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S1567-1356(03)00174-0","volume":"4","author":"RK Gupta","year":"2003","unstructured":"Gupta RK, Patterson SS, Ripp S, Simpson ML, Sayler GS. Expression of the Photorhabdus luminescens lux genes (luxA, B, C, D, and E) in Saccharomyces cerevisiae. FEMS Yeast Res. 2003;4(3):305\u201313.","journal-title":"FEMS Yeast Res"},{"key":"13140_CR26","doi-asserted-by":"crossref","unstructured":"Gregor C, Pape JK. Autonomous bioluminescence imaging of single mammalian cells with the bacterial bioluminescence system. 2019;116(52):26491\u20136.","DOI":"10.1073\/pnas.1913616116"},{"key":"13140_CR27","doi-asserted-by":"crossref","unstructured":"Gregor C, Gwosch KC, Sahl SJ, Hell SW. Strongly enhanced bacterial bioluminescence with the ilux operon for single-cell imaging. 2018;115(5):962\u20137.","DOI":"10.1073\/pnas.1715946115"},{"key":"13140_CR28","doi-asserted-by":"crossref","unstructured":"Sharma A, Cz\u00e9gel D. Assembly theory explains and quantifies selection and evolution. 2023;622(7982):321\u20138.","DOI":"10.1038\/s41586-023-06600-9"},{"issue":"3","key":"13140_CR29","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.plasmid.2009.01.003","volume":"61","author":"LR Mesak","year":"2009","unstructured":"Mesak LR, Yim G, Davies J. Improved lux reporters for use in Staphylococcus aureus. Plasmid. 2009;61(3):182\u20137.","journal-title":"Plasmid"},{"issue":"8","key":"13140_CR30","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ja.2010.74","volume":"63","author":"LR Mesak","year":"2010","unstructured":"Mesak LR, Qi S, Villanueva I, Miao V, Davies J. Staphylococcus aureus promoter-lux reporters for drug discovery. J Antibiot. 2010;63(8):492\u20138.","journal-title":"J Antibiot"},{"issue":"1","key":"13140_CR31","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1128\/IAI.72.1.238-246.2004","volume":"72","author":"L Chen","year":"2004","unstructured":"Chen L, Wang J, Zganiacz A, Xing Z. Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis. Infect Immun. 2004;72(1):238\u201346.","journal-title":"Infect Immun"},{"issue":"3","key":"13140_CR32","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1128\/AAC.00595-10","volume":"55","author":"MA De Groote","year":"2011","unstructured":"De Groote MA, Gilliland JC, Wells CL, Brooks EJ, Woolhiser LK, Gruppo V, Peloquin CA, Orme IM, Lenaerts AJ. Comparative studies evaluating mouse models used for efficacy testing of experimental drugs against Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2011;55(3):1237\u201347.","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"13140_CR33","doi-asserted-by":"publisher","first-page":"4195","DOI":"10.1128\/IAI.69.7.4195-4201.2001","volume":"69","author":"JL Flynn","year":"2001","unstructured":"Flynn JL, Chan J. Tuberculosis: latency and reactivation. Infect Immun. 2001;69(7):4195\u2013201.","journal-title":"Infect Immun"},{"issue":"1","key":"13140_CR34","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.tube.2013.07.004","volume":"94","author":"IM Orme","year":"2014","unstructured":"Orme IM. A new unifying theory of the pathogenesis of tuberculosis. Tuberc (Edinb Scotl). 2014;94(1):8\u201314.","journal-title":"Tuberc (Edinb Scotl)"},{"key":"13140_CR35","doi-asserted-by":"crossref","unstructured":"Druszczy\u0144ska M, Godkowicz M. Cytokine Receptors-Regulators of Antimycobacterial Immune Response. 2022, 23(3).","DOI":"10.3390\/ijms23031112"},{"key":"13140_CR36","doi-asserted-by":"crossref","unstructured":"Volynets GP, Tukalo MA. Novel isoniazid derivative as promising antituberculosis agent. 2020, 15(10):869\u201379.","DOI":"10.2217\/fmb-2019-0085"},{"issue":"10","key":"13140_CR37","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.1016\/j.ejmech.2009.05.009","volume":"44","author":"MJ Hearn","year":"2009","unstructured":"Hearn MJ, Cynamon MH, Chen MF, Coppins R, Davis J, Joo-On Kang H, Noble A, Tu-Sekine B, Terrot MS, Trombino D, et al. Preparation and antitubercular activities in vitro and in vivo of novel Schiff bases of isoniazid. Eur J Med Chem. 2009;44(10):4169\u201378.","journal-title":"Eur J Med Chem"},{"issue":"1\u20132","key":"13140_CR38","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.tube.2003.08.004","volume":"84","author":"S Mohamad","year":"2004","unstructured":"Mohamad S, Ibrahim P, Sadikun A. Susceptibility of Mycobacterium tuberculosis to isoniazid and its derivative, 1-isonicotinyl-2-nonanoyl hydrazine: investigation at cellular level. Tuberc (Edinb Scotl). 2004;84(1\u20132):56\u201362.","journal-title":"Tuberc (Edinb Scotl)"},{"issue":"11","key":"13140_CR39","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1164\/rccm.201910-1960OC","volume":"201","author":"KE Dooley","year":"2020","unstructured":"Dooley KE, Miyahara S, von Groote-Bidlingmaier F, Sun X, Hafner R, Rosenkranz SL, Ignatius EH, Nuermberger EL, Moran L, Donahue K, et al. Early Bactericidal Activity of Different Isoniazid Doses for Drug-Resistant Tuberculosis (INHindsight): A Randomized, Open-Label Clinical Trial. Am J Respir Crit Care Med. 2020;201(11):1416\u201324.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"13140_CR40","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1093\/cid\/ciw376","volume":"63","author":"P Nahid","year":"2016","unstructured":"Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, Chaisson LH, Chaisson RE, Daley CL, Grzemska M, et al. Official American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clin Infect diseases: official publication Infect Dis Soc Am. 2016;63(7):e147\u201395.","journal-title":"Clin Infect diseases: official publication Infect Dis Soc Am"},{"key":"13140_CR41","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.meegid.2016.09.004","volume":"45","author":"AN Unissa","year":"2016","unstructured":"Unissa AN, Subbian S, Hanna LE, Selvakumar N. Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis. Infect Genet evolution: J Mol Epidemiol evolutionary Genet Infect Dis. 2016;45:474\u201392.","journal-title":"Infect Genet evolution: J Mol Epidemiol evolutionary Genet Infect Dis"},{"issue":"8","key":"13140_CR42","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1002\/eji.201646349","volume":"46","author":"LH Yamashiro","year":"2016","unstructured":"Yamashiro LH, Eto C, Soncini M, Horewicz V, Garcia M, Schlindwein AD, Grisard EC, Rovaris DB, B\u00e1fica A. Isoniazid-induced control of Mycobacterium tuberculosis by primary human cells requires interleukin-1 receptor and tumor necrosis factor. Eur J Immunol. 2016;46(8):1936\u201347.","journal-title":"Eur J Immunol"},{"issue":"27","key":"13140_CR43","doi-asserted-by":"publisher","first-page":"12239","DOI":"10.1073\/pnas.1000643107","volume":"107","author":"Y Kong","year":"2010","unstructured":"Kong Y, Yao H, Ren H, Subbian S, Cirillo SL, Sacchettini JC, Rao J, Cirillo JD. Imaging tuberculosis with endogenous beta-lactamase reporter enzyme fluorescence in live mice. Proc Natl Acad Sci USA. 2010;107(27):12239\u201344.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"14\u201315","key":"13140_CR44","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.micinf.2009.08.005","volume":"11","author":"F Heuts","year":"2009","unstructured":"Heuts F, Carow B, Wigzell H, Rottenberg ME. Use of non-invasive bioluminescent imaging to assess mycobacterial dissemination in mice, treatment with bactericidal drugs and protective immunity. Microbes Infect. 2009;11(14\u201315):1114\u201321.","journal-title":"Microbes Infect"},{"issue":"3","key":"13140_CR45","doi-asserted-by":"publisher","first-page":"106620","DOI":"10.1016\/j.ijantimicag.2022.106620","volume":"60","author":"JJ Wilkins","year":"2022","unstructured":"Wilkins JJ, Svensson EM, Ernest JP, Savic RM, Simonsson USH, McIlleron H. Pharmacometrics in tuberculosis: progress and opportunities. Int J Antimicrob Agents. 2022;60(3):106620.","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"13140_CR46","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nrmicro3200","volume":"12","author":"V Dartois","year":"2014","unstructured":"Dartois V. The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells. Nat Rev Microbiol. 2014;12(3):159\u201367.","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"13140_CR47","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/jps.2600650306","volume":"65","author":"AA Hakim","year":"1976","unstructured":"Hakim AA, Grand NG. Mechanism of action of BCG vaccine on neoplastic proliferation and host immune responses. J Pharm Sci. 1976;65(3):339\u201343.","journal-title":"J Pharm Sci"},{"key":"13140_CR48","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.3389\/fimmu.2020.01452","volume":"11","author":"E Nemes","year":"2020","unstructured":"Nemes E, Khader SA, Swanson RV, Hanekom WA. Targeting Unconventional Host Components for Vaccination-Induced Protection Against TB. Front Immunol. 2020;11:1452.","journal-title":"Front Immunol"},{"issue":"1","key":"13140_CR49","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1038\/s41598-022-06351-z","volume":"12","author":"A Hoori","year":"2022","unstructured":"Hoori A, Hu T, Lee J, Al-Kindi S, Rajagopalan S, Wilson DL. Deep learning segmentation and quantification method for assessing epicardial adipose tissue in CT calcium score scans. Sci Rep. 2022;12(1):2276.","journal-title":"Sci Rep"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13140-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13140-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13140-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:50:42Z","timestamp":1781646642000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13140-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,11]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13140"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13140-w","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,11]]},"assertion":[{"value":"21 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in full compliance with national biosafety and ethical research standards. The study protocol was first reviewed and approved by the Institutional Biosafety Committee (IBC) of the National Institute of Health, the KDCA (Approval No. KCDC-IBC-20-030). Use of genetically modified\n                      M.tb\n                      strains was authorized by the KDCA, the national competent authority for Living Modified Organism (LMO) research under the Act on Transboundary Movements of LMO (Approval No. 20-RDM026). Additionally, all animal procedures were carried out under Biosafety Level 3 (BSL-3) conditions and were approved by the Institutional Animal Care and Use Committee (IACUC) of the KDCA (Approval No. KCDC-IACUC-21-009).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1083"}}